| Thailand | Turkey | Austria | |
| Stem cell therapy for HIV | from $12,000 / ฿408,000 | from $18,000 / ฿612,000 | from $50,000 / ฿1,700,000 |
Thailand has been a leader in HIV/AIDS research and treatment, and the country provides free or low-cost medical care for people living with HIV. The Thai government has also been a leader in developing anti-retroviral therapies (ART), and as a result, Thailand has one of the lowest rates of HIV/AIDS-related deaths in the world.
There are two types of ART available in Thailand: first-line therapy and second-line therapy. First-line therapy is a combination of three drugs typically used to treat people who have just been diagnosed with HIV. Second-line therapy is a combination of four drugs typically used to treat people who have developed resistance to first-line therapies.
There are also several different second-line therapies available in Thailand, and treatment choice again depends on the patient's unique medical history and drug resistance profile. The most common second-line therapies in Thailand are: Prezista (darunavir), Intelence (etravirine), and Viracept (nelfinavir).
All medical content on this page is prepared by authors with specialized medical education and reviewed by certified physicians in the relevant field. Medical review by Fahad Mawlood, Medical Editor & Data Scientist.
Last updated: April 1, 2025.
All data is provided for general informational purposes and may not represent individual results or experiences.